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Introduction
The precise localization of proteins to intracellular and plasma 
membrane domains is important for their proper function. Some 
intracellular proteins that play roles at the plasma membrane are 
modifi  ed by the addition of long-chain fatty acids that mediate 
protein targeting to the membrane (Dunphy and Linder, 1998). 
For example, the cotranslational attachment of myristic acid to 
an N-terminal glycine or the addition of fatty acids such as pal-
mitate by thioester linkage to cysteine residues target proteins to 
specifi  c subcellular compartments (Smotrys and Linder, 2004).
Palmitate is a 16-carbon saturated fatty acid that is at-
tached to proteins posttranslationally. This modifi  cation increases 
the hydrophobicity of the protein, thereby facilitating interactions 
with lipid bilayers. In neurons, at least 32 proteins have been 
shown to be palmitoylated. These include channels, cell adhe-
sion molecules, and signaling proteins as well as the presynap-
tic proteins cysteine string protein (CSP), synaptotagmin I 
(Syt I), SNAP25, neuronal synaptobrevin (n-Syb), and Huntingtin 
(Htt; el-Husseini Ael and Bredt, 2002; Smotrys and Linder, 
2004). Unlike myristoylation and isoprenylation, which are per-
manent modifi  cations, the palmitoylation of proteins is regu-
lated via a cycle of enzymes that add and remove palmitate 
(Smotrys and Linder, 2004). The reversibility of palmitoylation 
of neuronal proteins is likely to be an important regulatory event, 
as patients with mutations in palmitoyl-protein thioesterase 1 
(PPT1), which removes palmitate, exhibit a debilitating and 
early onset neuronal degeneration leading to childhood death 
(Vesa et al., 1995).
Recently, palmitoyl transferases (PATs) were discovered 
in Saccharomyces cerevisiae (Lobo et al., 2002; Roth et al., 
2002). The defi  ning feature of this family is the presence of a 
cysteine-rich domain (CRD) with an Asp-His-His-Cys (DHHC) 
motif, and it is required for PAT activity both in vitro and 
in vivo. Proteins with DHHC-CRD are conserved from yeast to 
mammals. Genetic and biochemical studies have identifi  ed sub-
strates for several of the seven DHHC proteins in S. cerevisiae 
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(Lobo et al., 2002; Roth et al., 2002), and proteomic analyses 
have expanded the repertoire of substrates for this family of en-
zymes signifi  cantly (Roth et al., 2006). Although the number of 
DHHC proteins in yeast is limited, fl  ies contain 20 and mam-
mals 23 DHHC proteins. Their tissue distribution and subcellular 
localization has been recently documented (Ohno et al., 2006). 
However, the in vivo role of these PATs in neurons has not 
been established.
In this study, we report a novel genetic screen that allowed 
us to identify mutations that affect neurotransmitter release. 
This screen led to the identifi  cation of Drosophila melanogaster 
htt-interacting protein 14 (hip14), a protein that has not been 
implicated previously in synaptic transmission but has been 
shown to palmitoylate Htt in vertebrates (Yanai et al., 2006). 
The synaptic defects associated with the loss of hip14 show 
striking similarities with the loss of csp (Zinsmaier et al., 1994). 
In addition, CSP as well as SNAP25 are mislocalized in hip14 
mutants, and palmitoylation of CSP is critical for its synaptic 
localization. In contrast, Syt I and postsynaptic density 95 
(PSD-95)/Discs large (DLG), which can be modifi  ed by HIP14 
in vitro (Huang et al., 2004), are localized properly in hip14 
mutants. Based on biochemical data and functional rescue assays, 
our data not only point to the importance of palmitoylation in 
synaptic function but also reveal CSP as a novel and one of the 
main targets for HIP14 in vivo.
Results
Isolation of mutations in complementation 
group 3L1
To identify novel proteins that affect synaptic transmission, we 
performed a forward genetic screen on chromosome arm 3L 
 using  the  ey-FLP system (Stowers and Schwarz, 1999; Newsome 
et al., 2000). In previous 2L, 2R, and 3R chromosome arm screens, 
we selected fl  ies in the F1 generation with aberrant phototactic 
properties, and, of the progeny, we isolated mutants with abnor-
mal electroretinograms (ERGs), thereby measuring the ability of 
photoreceptors (PRs) to activate postsynaptic cells   (Verstreken 
et al., 2003, 2005; Mehta et al., 2005). Although neurotransmis-
sion mutants isolated from prior ey-FLP screens initially dis-
played reduced phototaxis in the F1 generation, many behaved 
normally in subsequent generations despite retaining their ERG 
defects (Fabian-Fine et al., 2003; Verstreken et al., 2003, 2005; 
Koh et al., 2004). Therefore, we modifi  ed the screening strategy 
and omitted the phototaxis assay. Thus, F1 fl  ies were directly 
subjected to ERG recordings. Of the 49,017 screened F1 fl  ies, 
1,077 were crossed and rescreened in the F2 generation. 77 were 
eventually retained as mutants with abnormal ERGs. Com-
plementation tests with mutants previously shown to affect syn-
aptic transmission identifi  ed two new alleles of csp (Zinsmaier 
et al., 1994) and one new allele of SNAP (Ordway et al., 1994), 
demonstrating the specifi  city of the strategy. Upon further com-
plementation analysis, we identifi  ed eight novel complementa-
tion groups with two or more alleles. Here, we describe 3L1, 
a complementation group with three alleles: 3L1
1, 3L1
2, and 3L1
3. 
As shown in Fig. 1 A, all 3L1 mutants show lack of on-off tran-
sients but exhibit normal depolarization. By isolating mutants 
with these ERG defects, we and others have been able to identify 
genes that affect synaptic function or development (Zinsmaier 
et al., 1994; Stowers et al., 2002; Verstreken et al., 2003).
The ERG phenotype suggests that the PRs fail to properly 
transmit signals to postsynaptic neurons. This may be caused by 
(1) functional impairment of the neurotransmission machinery 
or (2) aberrant synapse formation. To test whether develop-
mental defects are present at the light microscopy level, we fi  rst 
stained adult brains with the PR-specifi  c antibody against cha-
optin, mAb 24B10 (Fujita et al., 1982). The Drosophila com-
pound eye consists of  800 units, each comprised of eight PR 
cells that project into the lamina (R1–R6) or into two separate 
layers in the medulla (R7–R8; Fig. 1 B). In control fl  ies, mAb 
24B10 staining reveals a highly regular array of terminals in the 
medulla (Fig. 1 B). Similarly, 3L1 mutant PRs display a regular 
array of terminals in the medulla and no obvious defects in axo-
nal targeting (Fig. 1 C). To determine whether R1–R6 PRs dis-
play defects in synapse formation, we also analyzed synaptic 
terminals in control and 3L1 mutant laminae by transmission 
EM (TEM). In controls, R1–R6 terminals are organized into 
units called cartridges, with each cartridge containing six PR 
terminals surrounding the postsynaptic lamina monopolar cell 
bodies (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200710061/DC1). Notably, the cartridge organization is pre-
served in the mutants (Fig. S1), indicating no obvious axonal 
sorting or targeting defects in the laminae. Thus, the ERG defects 
are likely caused by aberrant synaptic transmission rather than 
morphological disturbances.
TEM of PR synapses in the lamina also allows us to assess 
some ultrastructural features, including the number of mito-
chondria, number of active zones, and size, number, and shape 
of glial cell invaginations or capitate projections. The capitate 
projections are thought to be centers of endocytosis in PR termi-
nals (Fabian-Fine et al., 2003). Interestingly, as shown in Fig. 1 
(D–F; and Fig. S1), capitate projections are often shallow in 
mutants compared with controls, suggesting that mutations in 
3L1 may affect synaptic function in the visual system.
3L1 encodes Drosophila hip14
To identify the 3L1 gene, we mapped the lesions in the mutants 
using P-element meiotic recombination (Zhai et al., 2003). 
Rough mapping placed 3L1 in the 72A–C cytological interval 
and showed that the mutations fail to complement Df(3L)brm11 
(Fig. 2 A). Meiotic fi  ne mapping mapped 3L1 between KG00222 
and EY12630. Sequencing of CG6017 showed that 3L1
1 contains 
a Cys452Tyr mutation, 3L1
2 contains a 26-bp deletion leading to 
a premature stop codon at position 312, and 3L1
3 has a pre-
mature stop codon at position 432 (Fig. 2 B). CG6017 encodes a 
homologue of the human hip14 or DHHC17 and yeast Akr1p 
(ankyrin repeat-containing protein; Singaraja et al., 2002). 
Therefore, we renamed 3L1
1 as hip14
1, 3L1
2 as hip14
2, and 3L1
3 
as hip14
3. Because Df(3L)brm11 is the smallest deletion that re-
moves CG6017, we tested the three hip14 alleles in trans to the 
defi  ciency to determine the severity of these mutations. All trans-
heterozygous combinations die as pharate adults. The notion that 
all alleles are similar in severity over a   defi  ciency suggests that 
hip14
1, hip14
2, and hip14
3 are all either null or severe hypomorphic HIP14 TARGETS CSP TO SYNAPTIC VESICLES • OHYAMA ET AL. 1483
Figure 1.  Characterization of the ey-FLP screen phenotypes of 3L1 mutants. (A) ERGs of controls (y w ey-FLP GMR-lacZ; FRT80B/RpS17
4 P{w
+} FRT80B) 
and 3L1 mutants (y w ey-FLP GMR-lacZ; 3L1
1, 3L1
2, or 3L1
3 FRT80B/RpS17
4 P{w
+} FRT80B). The positions of on and off transients are indicated by gray 
arrowheads. (B and C) Confocal images showing control (y w ey-FLP GMR-lacZ; FRT80B/RpS17
4 P{w
+} FRT80B) and 3L1 mutant (y w ey-FLP GMR-lacZ; 
3L1
2 FRT80B/RpS17
4 P{w
+} FRT80B) adult brains stained with mAb 24B10. (D and E) EM of control (D) and 3L1
2 mutant (E) PR terminals in the lamina (for 
genotypes, see A). Some of the capitate projections (cp) and mitochondria (m) are indicated. (F) Quantiﬁ  cation of capitate projection distribution in controls 
and 3L1
1, 3L1
2, and 3L1
3 mutants. Error bars represent SEM. Bars: (B and C) 50 μm; (D and E) 1 μm.
alleles (Fig. 2 C). However, hip14
2 and hip14
3 homozygotes die 
as third instar larvae, indicating that the chromosomes carrying 
these alleles may carry other lethal mutations.
To determine whether the lethality and functional defects of 
the hip14 alleles can be rescued by CG6017, we generated a geno-
mic rescue construct (Fig. 2 A). This construct rescues the lethality JCB • VOLUME 179 • NUMBER 7 • 2007  1484
and ERG phenotypes associated with all trans-heterozygous 
mutants tested as well as hip14
1 homozygous animals (Fig. 2 D). 
Together, these results provide compelling evidence that le-
sions in hip14 are solely responsible for the defects observed in 
3L1 alleles.
HIP14 is conserved from yeast to humans over the entire 
length of the protein, sharing 50.8% identity with its human 
homologue and 31.3% identity with the yeast protein (Singaraja 
et al., 2002). Drosophila hip14 encodes a 71-kD protein with 
fi  ve ankyrin repeats, a DHHC-CRD typically found in PATs, 
Figure 2. Identiﬁ  cation of 3L1. (A) P-element ﬁ  ne mapping. Numbers separated by a backslash indicate recombinants out of total ﬂ  ies scored. Recombina-
tion distance in centiMorgans for the two closest P elements is indicated. A deﬁ  ciency that complements (green) and one that fails to complement (red) are 
shown. The calculated mapping location based on P-element mapping of 3L1 is shown as a red star, and the coding regions of nearby genes (black boxes) 
are shown. The region used for rescue is indicated by the blue bar. (B) Intron-exon structure of CG6017 and protein structure of HIP14. The start codon is 
marked in green, and the stop codon in indicated in red. The position of the N- or C-termEGFP of the genomic rescue constructs are indicated by the green 
inserts. HIP14 contains ﬁ  ve ankyrin repeats (green boxes), ﬁ  ve TMDs (yellow boxes), and a DHHC-CRD domain (blue box). The molecular nature of the 
three hip14 alleles is indicated. (C) Lethal stage of hip14 mutant combinations. (D) Lethality rescue of hip14 mutant combinations by genomic and cDNA 
constructs expressed using elav-GAL4. Columns are divided such that the yellow portion indicates the result from the genomic construct, and white indicates 
the result from the cDNA. (C and D) L3, animals do not survive beyond the third instar larval stage; P, death during late pupal stage; ND, not tested; R, res-
cued lethality.HIP14 TARGETS CSP TO SYNAPTIC VESICLES • OHYAMA ET AL. 1485
and fi  ve transmembrane domains (TMDs), suggesting it is an 
integral membrane protein (Singaraja et al., 2002; Huang et al., 
2004). Recently, a study has shown that the DHHC family of 
proteins functions as PATs, including the yeast homologue of 
hip14, Akr1p (Roth et al., 2002). In Drosophila, at least 20 genes 
share a common 50-residue zinc fi  nger–like sequence, which 
contains the DHHC-CRD. No analyses of mutants of any of 
these proteins in nematodes, fl  ies, or mice have been reported.
HIP14 is localized pre- and postsynaptically
Both mouse and human HIP14 are strongly expressed in the 
brain and heart, and immuno-EM studies suggest that HIP14 
localizes to the Golgi as well as to diverse vesicular structures 
present in the soma, axon, and dendrites of neurons (Singaraja 
et al., 2002; Huang et al., 2004). To determine the expression 
pattern and subcellular localization of HIP14 in Drosophila, we 
generated N- and C-terminal GFP-tagged genomic constructs 
(Fig. 2 B), as we failed to generate a specifi  c antibody. Both 
GFP-HIP14 constructs rescue the lethality defects of hip14 mu-
tants, suggesting that GFP-HIP14 is functional.
In stage 13–15 embryos, GFP-HIP14 is observed in the 
central nervous system (CNS) neuropil (Fig. 3, A and B). At the 
third instar larval stage, GFP-HIP14 is expressed in the ventral 
nerve cord (VNC) and is enriched in the neuropil (Fig. 3 C 
and Fig. S2 A, available at http://www.jcb.org/cgi/content/
full/jcb.200710061/DC1). At the neuromuscular junction (NMJ), 
GFP-HIP14 is localized to the pre- and postsynaptic regions 
(Figs. 3, D and E; and S2 B) and colocalizes extensively with 
presynaptic markers such as CSP (Fig. 3, F–H) and n-Syb 
(Fig. S2 C), suggesting that HIP14 is a presynaptic protein. 
Interestingly, similar to synaptic vesicle (SV)–associated proteins, 
HIP14 relocalizes to the presynaptic membrane upon SV deple-
tion in stimulated shibire
ts1 mutants at the restrictive temperature 
(Fig. 3, I–K). These data indicate that HIP14 localization at the 
synapse is dynamic. Combined with the fact that HIP14 harbors 
fi  ve TMDs, the data suggest, but do not demonstrate, that HIP14 
is a vesicle and presynaptic membrane–associated protein. Also, 
note that punctate GFP-HIP14 signals are also present in mus-
cles (Fig. 3, D and E). However, GFP-HIP14 fails to colocalize 
with the Golgi marker Lava Lamp (Papoulas et al., 2005) in mus-
cles, indicating that these punctae are not associated with Golgi 
structures. In summary, our analysis of the expression pattern of 
GFP-HIP14 indicates that HIP14 is enriched in the nervous sys-
tem throughout development but is also present in other tissues.
NMJs develop normally in hip14 mutants
Enhancer screens for genes involved in axon guidance and/or 
synaptogenesis at the Drosophila NMJ identifi  ed  CG6017/
hip14 (Kraut et al., 2001), suggesting that hip14 may play a role 
in growth cone guidance and/or synaptogenesis. However, our 
analysis of the hip14 PR projections failed to uncover any obvi-
ous morphological defects (Figs. 1, B and C; and S1). To test 
whether this is also the case at NMJs, we examined their mor-
phology with pre- and postsynaptic markers, including DLG/
PSD-95 (Lahey et al., 1994), the presynaptic membrane marker 
HRP (Jan and Jan, 1982), and Bruchpilot, an active zone com-
ponent (Kittel et al., 2006). However, similar to the PRs, we did 
not observe aberrant morphological features at the NMJs with 
any of these markers in hip14 mutants (Fig. 4, A and B).
To determine whether there are ultrastructural defects, we 
performed TEM experiments of third instar NMJ boutons. 
We fi nd that the mutants exhibit normal SV morphology and den-
sity, normal T-bar morphology, active zone length, and structure 
of the subsynaptic reticulum when compared with control ani-
mals (Fig. 4, C–F). These data indicate that similar to lamina 
synapses, NMJ synapses form properly in hip14 mutants and 
that hip14 does not contribute to axon guidance or synapto-
genesis in Drosophila. The data also suggest that there is no defect 
in endocytosis, as many Drosophila endocytic mutants analyzed 
to date exhibit a reduced number of vesicles and/or aberrantly 
sized vesicles (Zhang et al., 1998; Guichet et al., 2002;  Verstreken 
et al., 2003; Koh et al., 2004).
HIP14 is required for proper 
SV exocytosis
To assess the synaptic defects in hip14 mutants, we used the 
third instar NMJ. To determine whether HIP14 regulates SV 
  cycling at the synapse, we performed live imaging of vesicle 
cycling with FM 1-43 (Ramaswami et al., 1994). FM 1-43 is 
nonfl  uorescent in aqueous environments, but, when bound to 
membranes, its fl  uorescence quantum yield increases. Thus, newly 
endocytosed vesicles in the presence of FM 1-43 are fl  uorescently 
labeled by the dye, providing a quantitative measure of vesicle 
cycling. As shown in Fig. 5 A, when controls are stimulated for 
1 min with 90 mM K
+ in the presence of FM 1-43, synapses are 
brightly labeled, indicating effi  cient vesicle retrieval from the 
membrane during stimulation. However, hip14 mutants take up 
less dye ( 50–70% of control; Fig. 5 B), suggesting a defect in 
vesicle cycling. Unlike many endocytic mutants analyzed in 
Drosophila (Verstreken et al., 2003; Koh et al., 2004), EM anal-
ysis of hip14 mutants did not show a reduction in SV density 
(Fig. 4 C), suggesting that the reduced FM 1-43 uptake is not 
likely to be caused by a defect in endocytosis.
To determine whether exocytosis is impaired at hip14 syn-
apses, we stimulated mutant and control motor nerves at 0.2 Hz 
in 1 mM Ca
2+ and recorded excitatory junctional potentials (EJPs) 
from the muscle. The EJP amplitudes in hip14 mutants during 
low frequency stimulation are  33–40% of controls (wild type, 
39.4 ± 2.4 mV; hip14
1, 13.2 ± 1.4 mV; hip14
2, 18.9 ± 0.6 mV) 
at 23°C (Fig. 5, C and D), indicating that these mutants have a 
severe defect in evoked release. Furthermore, EJPs recorded 
from hip14 mutants at 30°C (0.2 Hz and 1 mM Ca
2+) are se-
verely reduced (wild type, 42.8 ± 3.7 mV; hip14
2, 5.9 ± 1.5 mV; 
Fig. 5, E and F), suggesting that the reduced EJP amplitudes 
in hip14 mutants are temperature sensitive, similar to what 
is observed in csp mutants (Fig. 5, D and F; Zinsmaier et al., 
1994). These data demonstrate that HIP14 is required for 
proper exocytosis.
We also recorded miniature EJP amplitude and frequency. 
Both parameters are similar to controls (Fig. 5 G), suggesting 
normal transmitter loading and postsynaptic glutamate recep-
tor clustering. To further assess postsynaptic integrity, we 
  labeled control and mutant synapses for GluRIII, a subunit 
found in all glutamate receptor clusters (Petersen et al., 1997). JCB • VOLUME 179 • NUMBER 7 • 2007  1486
Figure 3.  Localization of HIP14. Confocal images from genomic GFP-tagged hip14 transgenic animals. (A and B) Stage 14 embryo (y w; P{w
+ NtermGFP-
hip14
+}) with GFP-HIP14 (green) and Fasciclin II (magenta). The GFP-HIP14 (green) channel is shown separately in B. (C) Third instar larval (y w; P{w
+ 
NtermGFP-hip14
+}) CNS with GFP-HIP14 (green) and DLG (magenta). (D and E) Third instar larvae NMJ boutons in genomic GFP-tagged hip14 transgenic 
animals (y w; P{w
+ NtermGFP-hip14
+}) with GFP-HIP14 (green) and DLG (magenta) to label the synaptic areas. The green channel is shown separately in E. 
(F–H) Third instar larval NMJ boutons in wild type (y w, shibire
ts/+; P{w
+ NtermGFP-hip14
+}/+) with GFP-HIP14 (green) and CSP (magenta) at ambient 
temperature. Both channels are separately shown in F and H. Images are single confocal sections. (I–K) Third instar larval NMJ boutons in shibire
ts mutant 
(y w, shibire
ts/Y; P{w
+ NtermGFP-hip14
+}/+) at restrictive temperature or 32°C with GFP-HIP14 (green) and CSP (magenta). Both channels are separately 
shown in I and K. Images are single confocal sections. Bars: (A and B) 20 μm; (C) 100 μm; (D and E) 10 μm; (F–K) 2 μm.HIP14 TARGETS CSP TO SYNAPTIC VESICLES • OHYAMA ET AL. 1487
GluRIII staining in hip14 mutants is not obviously different 
from controls (Fig. 5 H). These data suggest that HIP14 does 
not affect postsynaptic receptor clustering or function.
Because HIP14 is expressed both pre- and postsynaptically 
at the Drosophila NMJ (Fig. 3, D–H), we assessed whether the 
overexpression of HIP14 in neurons (elav-GAL4; UAS-cDNAhip14) 
was able to rescue the mutant phenotypes. When overexpressed 
in hip14 mutants, UAS-cDNAhip14 not only rescues the lethal-
ity but also restores the EJP amplitude in hip14 mutants to 
  control levels (wild type, 39.4 ± 2.4 mV; elav-GAL4/+; UAS-
cDNAhip14/+; hip14
2/Df, 37.1 ± 1.7 mV; Fig. 5 D). Collec-
tively, these data indicate that the reduced EJP amplitudes 
Figure 4.  NMJ morphology is normal in hip14 mutants. (A) Confocal images of the third instar larval NMJ on muscles 6 and 7 labeled with anti-HRP 
(green) to mark all neuronal membranes and DLG (magenta) to label the pre- and postsynaptic regions in control (y w; FRT80B) and hip14
2/Df mutants 
(y w ey-FLP GMR-lacZ; hip14
2 FRT80B/Df(3L)brm11). (B) mAb nc82 (Bruchpilot) and DLG labeling of boutons of control (y w; FRT80B) and hip14
2/Df mu-
tants (y w ey-FLP GMR-lacZ; hip14
2 FRT80B/Df(3L)brm11). (C) Ultrastructure of NMJ boutons in control (y w; FRT80B) and hip14
2/Df mutants (y w ey-FLP 
GMR-lacZ; hip14
2 FRT80B/Df(3L)brm11). (D–F) Quantiﬁ  cation of synaptic features. Error bars represent SD. Bars: (A) 20 μm; (B) 2 μm; (C) 0.5 μm.JCB • VOLUME 179 • NUMBER 7 • 2007  1488
Figure 5.  Evoked neurotransmitter release is impaired in hip14 mutants. (A and B) FM 1-43 dye uptake on controls (y w; FRT80B), hip14
1/Df mutants 
(y w ey-FLP GMR-lacZ; hip14
1 FRT80B/Df(3L)brm11), and hip14
2/Df mutants (y w ey-FLP GMR-lacZ; hip14
2 FRT80B/Df(3L)brm11). (A) Preparations were 
stimulated for 1 min in the presence of 4 μM of dye, 90 mM KCl, and 1.5 mM Ca
2+ to label the exo-endo cycling pool. (B) Quantiﬁ  cation of the labeling 
intensity of FM 1-43 shown in A. (C and E) Sample EJPs recorded in 1 mM of external Ca
2+ at 0.2 Hz in controls and hip14
2/Df. Bath temperature was kept 
at 23 (C) or 30°C (E). (D and F) Quantiﬁ  cation of EJP amplitudes recorded at 23°C are shown in D for all genotypes, including csp mutants (cspu
1/cspx
1)HIP14 TARGETS CSP TO SYNAPTIC VESICLES • OHYAMA ET AL. 1489
observed in hip14 mutants stem from impaired presynaptic 
function and demonstrate an essential function for the gene 
in the nervous system.
CSP and SNAP25 are not properly 
localized at hip14 NMJs
Based on in vitro assays, mammalian HIP14 and the yeast ho-
mologue Akr1p are PATs (Babu et al., 2004; Huang et al., 2004) 
and are able to covalently attach palmitic acid to cysteine resi-
dues, thereby regulating the localization of various proteins. 
 Although HIP14 is able to palmitoylate many neuronal proteins, 
including PSD-95, GAD43 (growth-associated protein 43), Syt I, 
SNAP25, and Htt in cell culture systems (Huang et al., 2004), 
the role and substrate specifi  city of HIP14 in neurons remain to 
be determined.
Therefore, we examined the levels and protein distribu-
tion of presynaptic components that are known to be palmi-
toylated, including PSD-95/DLG, Syt I, n-Syb, SNAP25, and 
CSP (el-Husseini Ael and Bredt, 2002) in control and hip14 mu-
tant boutons. We stained NMJs with anti-DLG, which strongly 
labels the postsynaptic membrane as well as the most peripheral 
component of the presynaptic membrane (Lahey et al., 1994). 
We did not observe any differences between control and mutant 
NMJs (Fig. 4 A), indicating that DLG may not be a target for 
HIP14 in Drosophila. Therefore, we were able to use DLG to 
counterstain boutons that were labeled with Syt I, n-Syb, CSP, 
and SNAP25. As shown in Fig. 6 (A, B, and E), the levels and 
protein distributions of Syt I and n-Syb are similar in hip14 when 
compared with controls. However, the levels of CSP and SNAP25 
are strongly reduced in the NMJ boutons of hip14 mutants (28 ± 
5.2% of control for CSP and 29 ± 2.4% of control for SNAP25; 
Fig. 6, C–E). These data suggest that HIP14 is important for the 
proper synaptic localization of CSP and SNAP25 but not for 
Syt I and n-Syb.
To test whether the reduction in CSP and SNAP25 at syn-
apses can be attributed to a decrease in the expression or mis-
localization of these proteins, we performed a Western blot 
using third instar larval brain tissue. Compared with controls, 
the amount of SNAP25 in mutant brain is not reduced on the 
Western blot (Fig. 6 F), suggesting that SNAP25 is translated 
properly but is mislocalized in the absence of HIP14. On the other 
hand, the level of CSP in mutant brains is somewhat reduced 
(Fig. 6 F). Interestingly, the molecular mass of CSP in hip14 mu-
tants is  6–7 kD less than in controls. This suggests that some 
posttranslational modifi  cation of CSP does not occur properly in 
hip14 mutants.
To determine whether the localization of CSP and SNAP25 
is altered in hip14 mutants, we examined its expression in the 
larval VNC, where neuronal cell bodies reside. In hip14 mutants, 
CSP and SNAP25 are much more diffuse and more prominently 
localized in neuronal cell bodies when compared with controls, 
in which CSP and SNAP25 are more enriched in the neuropil 
(Fig. 6, G and H; and Fig. S3 A, available at http://www.jcb.org/
cgi/content/full/jcb.200710061/DC1). This indicates that CSP 
and SNAP25 are not properly targeted to synapses in hip14 
mutants. Together, these data show that CSP and SNAP25 are 
dependent on HIP14 for their proper localization at synapses, 
a process that may depend on the HIP14 PAT activity.
Palmitoylation of CSP requires HIP14
The previous data are consistent with the hypothesis that HIP14 
palmitoylates CSP. CSP carries 11–13 palmitoylation sites (van 
de Goor and Kelly, 1996), and these posttranslational modifi  ca-
tions are necessary for traffi  cking the protein from the ER in 
cultured cells (Greaves and Chamberlain, 2006). To assess the 
palmitoylation state of CSP in hip14 mutants, we compared 
wild-type CSP with CSP that is stripped of its palmitate resi-
dues through chemical treatment with hydroxylamine, a com-
pound that has been shown to effi  ciently cleave posttranslational 
fatty acyl thioester groups of proteins (van de Goor and Kelly, 
1996). As shown in Fig. 6 I (lane 1), wild-type CSP isolated 
from control third instar larvae migrates as a doublet at 38 kD. 
The protein isolated from wild-type animals was then treated 
with hydroxylamine (Fig. 6 I, lane 2) and compared with CSP 
from hip14 mutants (Fig. 6 I, lane 3). The chemically depalmi-
toylated wild-type CSP (Fig. 6 I, lane 2) as well as treated and 
untreated CSP isolated from hip14 mutants (Fig. 6 I, lane 4) all 
migrate at exactly the same molecular mass,  6 kD smaller than 
the wild-type protein, which is similar to a mutant CSP (serine 
string protein [SSP]) in which the 11 palmitoylated cysteines 
were replaced with serines (Arnold et al., 2004). These data 
  indicate that CSP is indeed palmitoylated (van de Goor and 
Kelly, 1996; Chamberlain and Burgoyne, 1998) and, more impor-
tantly, that all or most palmitate residues of CSP are lacking in 
hip14 mutants.
Overexpressed CSP in hip14 mutants does 
not localize to NMJs and fails to rescue 
exocytic defects
In addition to the severe reduction of CSP at hip14 synapses, 
our electrophysiological data show that hip14 mutants exhibit 
exocytic defects that are temperature sensitive (Fig. 5, C–F). 
These phenotypes are reminiscent of those associated with the 
complete loss of function of CSP, which exhibits about a 50% 
reduction in evoked response at 23°C and an almost complete 
loss of synaptic transmission at 30°C (Fig. 5, D and F; Zinsmaier 
et al., 1994). Furthermore, the csp- and hip14-associated pheno-
types are also very different from the rather mild electrophysio-
logical defects associated with the loss of SNAP25, probably 
because of redundancy with SNAP24 (Vilinsky et al., 2002). 
Thus, the protein localization data, the biochemical data, and the 
electrophysiological data are all consistent with the hypothesis that 
and cDNA rescue by presynaptic expression (elav-GAL4/+; UAS-cDNAhip14/+; hip14
2/Df(3L)brm11). Quantiﬁ  cation for controls, hip14
2/Df, and csp 
mutants at 30°C is shown in F. Recordings were performed for 1 min, and 12 EJP amplitudes were averaged per recording. (G) Frequency and amplitude 
of miniature synaptic currents in hip14 mutants. Miniature EJPs were recorded in the presence of 5 μM tetrodotoxin in 0.5 mM Ca
2+. (H) GluRIII immuno-
staining at NMJs of control and hip14
2/Df animals. (B, D, F, and G) The number of animals tested is indicated in the bars. Error bars represent SEM. 
**, P < 0.01 (t test). Bars: (A) 5 μm; (H) 2 μm.JCB • VOLUME 179 • NUMBER 7 • 2007  1490
Figure 6.  CSP and SNAP25 are mislocalized in hip14 mutants. (A–D) Confocal images showing labeling of control (y w; FRT80B; left) and hip14
2/Df 
mutant (y w ey-FLP GMR-lacZ; hip14
2 FRT80B/Df(3L)brm11; right) boutons on muscle 4 segment A4 for Syt I (A), n-Syb (B), CSP (C), and SNAP25 
(D; green). (E) Quantiﬁ  cation of labeling intensity for synaptic markers shown in A–D. **, P < 0.01 (t test). Error bars represent SEM. The number of 
animals tested is indicated in the bars. (F) Western blots of larval brain extracts of controls, hip14
1/Df, and hip14
2/Df using antibodies against CSP 
and SNAP25. Protein loading normalized using anti-actin labeling. (G and H) Confocal images showing labeling of control (G) and hip14
2/Df mutant 
(H) VNC with CSP (green) and DLG (magenta). The green channel is shown separately in the bottom panel. n, neuropil; c, cell body. (I) Hydroxylamine 
treatment of hip14 mutant brains. Larval brain extracts of controls (lanes 1 and 2) and hip14
2/Df (lanes 3 and 4) were treated with hydroxylamine HIP14 TARGETS CSP TO SYNAPTIC VESICLES • OHYAMA ET AL. 1491
much of the phenotype in hip14 mutants is caused by a defect in 
CSP function, and the defect in evoked release observed in 
hip14 mutants may be predominantly caused by a failure of un-
modifi  ed CSP to be localized to the synapse.
To explore whether traffi  cking of CSP to synapses is solely 
or predominantly dependent on palmitoylation by HIP14, we over-
expressed CSP neuronally in hip14 mutants. We overexpressed 
wild-type UAS-CSP2, one of the three Drosophila isoforms 
expressed in neurons (Nie et al., 1999), which was previously 
shown to rescue csp-null mutants. In controls, CSP2 overexpres-
sion induced a fourfold up-regulation of CSP at the third instar 
larval NMJ relative to control animals (Fig. S4, A and B; avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710061/DC1). 
However, in hip14 mutants, the levels of CSP at the boutons are 
not or are at most minimally up-regulated when compared with 
hip14 mutants that do not overexpress CSP (Fig. 7, A and C). 
These data again suggest that the decrease of CSP at NMJ bou-
tons in hip14 mutants is not caused by translational repression 
and that any CSP targeting from the cell body to the synapses 
depends on HIP14.
To further determine whether the palmitoylation of CSP is 
necessary for targeting of the protein to the synapse, we exam-
ined whether SSP (Arnold et al., 2004) localizes to NMJ boutons. 
Similar to wild-type CSP in hip14 mutants, SSP does not or very 
poorly localizes to NMJ boutons when expressed in csp-null 
mutants (Fig. 7 D). SSP is produced but localizes to the cell 
body of the neurons (Fig. S3 B), which is similar to wild-type 
CSP overexpressed in hip14 mutants. Collectively, these data 
further indicate that the palmitoylation of CSP is necessary for 
targeting the protein to the synapse.
Chimeric CSP localizes to synapses and 
signiﬁ  cantly rescues hip14 mutants
Because CSP cannot be targeted to NMJ boutons in hip14 mu-
tants, even when overexpressed, we generated a chimeric CSP 
in which full-length CSP2 is sandwiched between the N-termi-
nal n-Syb sequence (111 bp) and the C-terminal n-Syb TMD 
(SybTMD; 234 bp) to forcibly target CSP to SVs at synapses. 
We expressed this chimeric CSP neuronally in csp-null mutants 
using elav-GAL4. Interestingly, the SybTMD-CSP2 protein is 
not only able to rescue the lethality of csp mutants but also the 
paralytic phenotype at 30°C even though it is expressed at lower 
levels than the wild-type CSP2 (Fig. S4, B–D). These data indi-
cate that SybTMD-CSP2 is expressed and functional and fur-
ther suggest that vesicle tethering of CSP is important for the 
function of CSP.
To test whether SybTMD-CSP2 localizes to NMJ synapses 
independently of HIP14, we determined its localization in hip14 
mutants. As shown in Fig. 7 E and in contrast to wild-type CSP2 
in hip14 mutants (Fig. 7 C), the chimeric CSP at third instar larvae 
boutons is easily detectable. This difference in immunostaining is 
not caused by elevated levels of expression of SybTMD-CSP2 
when compared with wild-type CSP (Fig. S4, A–D).
Because SNAP25 may be a substrate for the CSP chaper-
one complex, the mislocalization of SNAP25 in hip14 mutants 
may be caused by the mislocalization of CSP and not necessarily 
because of defective palmitoylation. However, our data suggest 
that this is not the case, as the SNAP25 levels are still reduced in 
hip14 mutants that express the chimeric CSP that localizes to 
NMJs (Fig. S5, available at http://www.jcb.org/cgi/content/full/
jcb.200710061/DC1). Thus, HIP14-mediated palmitoylation of 
SNAP25 seems critical for its synaptic localization.
If the exocytic defects in hip14 mutants largely stem from 
the mislocalization of CSP (Fig. 5, C–F), SybTMD-CSP2 should 
be able to at least partially rescue the exocytic defects in hip14 
mutants. Indeed, when SybTMD-CSP2 is expressed neuronally 
in hip14 mutants, the EJPs are signifi  cantly rescued at 23°C (Fig. 7, 
F and G). Furthermore, at 30°C, EJPs in hip14 mutants recov-
ered from 5 to 50% of control (Fig. 7 G). In contrast, wild-type 
CSP2 expression in hip14 neurons does not show signifi  cant 
rescue of the EJP phenotype (Fig. 7, F and G). These data indi-
cate that a signifi  cant portion of the neurotransmission defects 
in hip14 mutants result from depletion of CSP at the synapse 
and further indicate the importance of palmitoylation and vesi-
cle association for the normal function of CSP.
Discussion
Posttranslational modifi   cation by palmitate is critical for 
the proper localization and function of numerous proteins 
(Smotrys and Linder, 2004). The enzymes that mediate the ad-
dition of palmitate to proteins, PATs, were originally studied 
in S. cerevisiae (Roth et al., 2002) and are characterized by 
the presence of a CRD with an embedded DHHC motif that 
mediates the PAT activity of enzymes. Although DHHC-CRD 
proteins are conserved from yeast to mammals, no mutations 
in these proteins have been documented in any other model 
organism. Here, in an unbiased genetic screen to identify genes 
that affect synaptic transmission, we have identifi  ed mutants 
in hip14, a DHHC-CRD protein structurally conserved from 
yeast to man (Singaraja et al., 2002). Characterization of these 
mutants suggests that HIP14 plays an important role in synaptic 
function by mediating the palmitoylation and proper targeting 
of specifi  c presynaptic proteins.
The importance of proper protein palmitoylation in the 
nervous system has been suggested by several fi  ndings. For in-
stance, patients with lesions PPT1, a depalmitoylating enzyme, 
suffer from an early onset neurodegeneration that leads to child-
hood death (Vesa et al., 1995). Loss of PPT1 in Drosophila has 
also been associated with a synaptic dysfunction based on ge-
netic interaction experiments (Buff et al., 2007). In addition, the 
presence of expanded repeats in pathogenic Htt protein has been 
shown to render it less amenable to palmitoylation, enhancing 
the formation of inclusion bodies (Yanai et al., 2006). However, 
the consequences on synaptic transmission of aberrant or absent 
palmitoylation in neurons have not been investigated in vivo.
(lanes 2 and 4) or Tris (lanes 1 and 3). After treatment, proteins were subjected to SDS-PAGE and immunoblotted with CSP antibodies. Bars: (A–D) 10 μm; 
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Figure 7.  Chimeric but not wild-type CSP rescues the localization of CSP and the exocytic defects in hip14 mutants. (A–E) Confocal images showing 
labeling of larval ﬁ  lets with CSP (green) and DLG (magenta) to indicate the synaptic areas. Genotypes: control (y w; FRT80B; A), hip14
2/Df mutant (y w ey-FLP 
GMR-lacZ; hip14
2 FRT80B/Df(3L)brm11; B), elav>csp2; hip14 (elav-GAL4/+; P{w
+ UAS-csp2}/+; hip14
2 FRT80B/Df (3L)brm11; C), elav>ssp; csp 
(elav-GAL4/+;; P{w
+ UAS-csp-11c/s}, cspu
1/cspx
1; D), and elav>SybTMD-csp2; hip14 (elav-GAL4/+; P{w
+ UAS-SybTMD-csp}/+ hip14
2 FRT80B/
Df(3L)brm11; E). CSP labeling is separately shown on the bottom panels. (F) Sample EJPs recorded in 1 mM Ca
2+ at 0.2-Hz stimulation at 23°C when wild-type HIP14 TARGETS CSP TO SYNAPTIC VESICLES • OHYAMA ET AL. 1493
Mammalian HIP14 is expressed ubiquitously but is most 
prominently present in the brain (Singaraja et al., 2002). Here, 
we fi  nd that GFP-HIP14 is expressed throughout the nervous 
system during development and in third instar larvae but is 
strongly enriched in the neuropil. Furthermore, the presynaptic 
expression of HIP14 rescues the lethality and phenotype of hip14 
mutants, suggesting that it plays a critical role in presynaptic 
function. This is further substantiated by the observations that the 
miniature EJP amplitude and frequency are similar to wild type 
and that GluRIII localization is normal. All DHHC proteins, 
with the exception of yeast Ynl155W, are integral membrane pro-
teins with four or more TMDs (Mitchell et al., 2006). The DHHC-
CRD motif is typically located between two TMDs and is 
predicted to face the cytosol (Politis et al., 2005). Human HIP14 
was shown to be localized at the Golgi and in cytoplasmic vesi-
cles marked with SNAP25 in cultured neurons or transfected 
cells (Huang et al., 2004). We fi  nd that HIP14 mostly colocal-
izes with CSP and n-Syb at the synapse. Because HIP14 relocal-
izes to the presynaptic membrane upon SV depletion and harbors 
several TMDs, these data are consistent with HIP14 being an 
SV and presynaptic membrane-associated protein.
There are 20 DHHC proteins in Drosophila, raising issues 
about the protein specifi  city of each DHHC protein family member. 
Because there are numerous DHHC proteins, it is likely that each 
protein has one or a few specifi  c target substrates. This may be 
un  surprising, as palmitoylation is a highly regulated event, and 
DHHC proteins are likely to be targeted to very specifi  c cellular 
compartments, where they act locally on few targets. A previous 
mammalian study in culture systems shows that HIP14 is a PAT 
and suggests that candidate targets include PSD-95/DLG, Htt, 
Syt I, SNAP25, GAD43, and GAD65 (Huang et al., 2004). In ad-
dition, RNAi knockdown analyses in neurons have provided 
evidence that HIP14 modulates palmitoylation-dependent pro-
tein traffi  cking of PSD-95, GAD65, and Htt (Huang et al., 2004; 
Yanai et al., 2006). However, the role of HIP14 in neuronal ac-
tivity and synaptic transmission had not been documented.
We fi nd that HIP14 directly regulates the localization of 
two important presynaptic proteins: CSP and SNAP25. How-
ever, we did not observe any difference in the localization of 
DLG, n-Syb, and Syt I. We focused on CSP for several reasons. 
First, the loss of SNAP25 in Drosophila causes very mild exo-
cytic defects. It has been proposed that this is the result of the re-
dundant function of SNAP24 (Vilinsky et al., 2002). Second, the 
electrophysiological phenotype associated with the loss of HIP14 
strongly resembles the unique temperature-sensitive pheno-
type associated with the loss of CSP (Zinsmaier et al., 1994), in-
dicating that CSP is one of the main targets of HIP14. Third, it was 
previously shown that CSP is heavily palmitoylated and that this 
posttranslational modifi  cation is required in vivo (van de Goor 
and Kelly, 1996; Arnold et al., 2004). Collectively, these data 
suggest that much of the phenotype we observe in hip14 mu-
tants is caused by the loss of CSP function. However, note that 
although the functional defects in hip14 strongly resemble those 
seen in csp mutants, the developmental defects, including the 
reduction in bouton number in csp mutants (Bronk et al., 2005), 
are not observed in hip14, indicating that palmitoylation-
independent roles for CSP in neurons also exist.
The SV-associated protein CSP is critical for regulating 
neurotransmitter release and has been shown to prevent neuronal 
degeneration (Fernandez-Chacon et al., 2004; Zinsmaier et al., 
1994). CSP binds the chaperone heat-shock cognate protein Hsc70 
and regulates its ATP activity, and this cooperativity is required for 
regulated neurotransmitter release at synaptic terminals (Bronk 
et al., 2001). These data have led to the proposal that CSP is a chap-
erone that renatures nerve terminal proteins that misfold during 
the continuous operation of the SV cycle, a view which is supported 
by genetic studies in mice and Drosophila (Zinsmaier et al., 1994; 
Fernandez-Chacon et al., 2004). Binding experiments suggest 
that the protective effect may be mediated by CSP interacting with 
candidate substrates such as the SV protein n-Syb and the plasma 
membrane protein Syntaxin (Zinsmaier and Bronk, 2001).
CSP possesses a cysteine-rich region containing a high 
density of cysteine residues (14 in a span of 24 amino acids in 
mammals). Most of these cysteines are palmitoylated, a process 
proposed to be necessary for the secretion of CSP from the ER 
(Chamberlain and Burgoyne, 1998; Greaves and Chamberlain, 
2006). Our data indicate that HIP14 is the PAT for CSP and that 
in the absence of HIP14, CSP is retained in the cell body. Further-
more, SSP is also retained in the cell body when overexpressed 
in neurons (Fig. S3 B). Thus, these data are consistent with a 
role for HIP14 in regulating the proper synaptic targeting of 
CSP. The observation that a chimeric CSP rescues much of the 
exocytic defects associated with the loss of hip14 mutants pro-
vides compelling evidence that a main function of HIP14 is the 
palmitoylation of CSP. This palmitoylation is most likely not 
only required in the cell body for proper targeting of CSP to the 
synaptic terminals; indeed, synaptic HIP14 may also play a role 
in a palmitoylation cycle occurring at synapses.
The loss of CSP and the expression of expanded Htt pro-
tein have both been shown to be associated with synaptic de-
fects in exocytosis and neuronal degeneration (Zinsmaier et al., 
1994; Fernandez-Chacon et al., 2004; Romero et al., 2007). 
  Interestingly, our preliminary analyses suggest that wild-type 
human Htt and 128Q-expanded human Htt proteins are both 
mislocalized in fl  ies lacking HIP14 (unpublished data). Thus, 
Htt also appears to be palmitoylated by HIP14 in Drosophila, 
which is similar to what has been observed in mice (Huang 
et al., 2004). Although we have not yet explored the effect of 
hip14 mutations on neuronal degeneration, it will be interesting 
to explore the relationship between HIP14, CSP, and Htt in the 
processes of synaptic transmission and neuronal degeneration 
in more detail.
CSP2 or chimeric CSP is overexpressed in hip14
2/Df neurons. (G) Quantiﬁ  cation of EJP amplitudes are recorded in 1 mM Ca
2+ at 23°C (black bars) and 
at 30°C (white bars) in controls, hip14 mutant, csp mutants (w, cspu
1/cspx
1), CSP2 overexpressed neuronally in hip14 mutant background, and SybTMD-
CSP2 overexpressed neuronally in hip14 mutant background. For recordings at 23°C (black bars), hip14
2/Df was used, whereas at 30°C (white bars), the 
hip14
2/hip14
1 allelic combination was used. Recordings were performed for 1 min at 0.2 Hz, and 12 EJP amplitudes were averaged per recording. 
*, P < 0.05; **, P < 0.01 (t test). Error bars represent SEM. The number of animals tested is indicated in the bars. Bars, 2 μm.JCB • VOLUME 179 • NUMBER 7 • 2007  1494
Materials and methods
Genetics and molecular biology
Control animals are isogenized (y w ey-FLP GMR-lacZ; FRT80B) unless other-
wise indicated. 3L1
1, 3L1
2, and 3L1
3 mutants (y w ey-FLP GMR-lacZ;3L1
x 
FRT80B/TM6B, Tb) were isolated from an ey-FLP ethane methyl sulfonate 
screen as described previously (Verstreken et al., 2003) with modiﬁ  cations. 
cspx
1 mutants and UAS-ssp (w;; P{w
+ UAS-csp-11c/s}, cspu
1) ﬂ  ies were 
provided by K. Zinsmaier (University of Arizona, Tucson, AZ). P-element 
stocks and deﬁ  ciencies were obtained from the Bloomington Drosophila 
Stock Center (Bellen et al., 2004; Parks et al., 2004), and 3L1 mapping 
was performed as described previously (Zhai et al., 2003).
We made a genomic rescue construct by PCR amplifying the 6.5-kb 
hip14 region from bacterial artiﬁ  cial chromosome clone AC093499. The 
fragment was cloned into the SalI restriction site of pP{CaSpeR-4} and 
  sequenced. A cDNA construct was made by PCR amplifying hip14 from 
expressed sequence tag clone LD10758. The fragment was cloned into 
NotI and XbaI sites of pP{UAST} and sequenced.
To generate genomic GFP-tagged constructs, we ﬁ  rst integrated an 
NheI site just before the ATG start codon (NtermGFP-HIP14) or after the 
hip14 stop codon (CtermGFP-HIP14) by site-directed mutagenesis (Strata-
gene). PCR-ampliﬁ  ed EGFP sequence was cloned into the NheI site.
We generated chimeric n-SybTMD-CSP constructs by PCR amplify-
ing 111-bp N-terminal and 234-bp C-terminal n-syb sequences from 
pP{UAST}-syb-GFP and the full-length CSP2 from pP{UAST}-csp2 (provided 
by K. Zinsmaier). In the next round of PCR, we fused them to generate 
N-terminal-Syb-csp2-C-terminal-Syb chimeric (SybTMD-csp2). After sequenc-
ing, SybTMD-csp2 was cloned into pP{UAST} at NotI and XbaI.
P{w
+ UAS-SybTMD-csp2} and P{w
+ UAS-csp2} were expressed 
using elav-GAL4. For analyses of CSP localization and physiology of 
third instar larvae, we generated elav-GAL4/+; P{w
+UAS-SybTMD-csp2} 
hip14
2 FRT80B/Df(3L)brm11 and elav-GAL4/+; hip14
2 FRT80B P{w
+ 
UAS-csp2}/Df(3L)brm11.
Immunohistochemistry and Western blotting
For staining third instar larvae and adults, brains were dissected in modi-
ﬁ  ed HL3 solution (110 mM NaCl, 5 mM KCl, 10 mM NaHCO3, 5 mM 
Hepes, 30 mM sucrose, 5 mM trehalose, and 10 mM MgCl2, pH 7.2) and 
ﬁ  xed in 4% formaldehyde for 20 min. Tissue was washed with PBS and 
permeabilized with 0.4% Triton X-100. For shibire
ts experiments, third in-
star larvae were dissected in modiﬁ  ed HL3 solution, incubated at 32°C for 
5 min, and stimulated in prewarmed modiﬁ  ed HL3 solution with 90 mM 
KCl and 1.5 mM Ca
2+ for 5 min. After stimulation, the samples were ﬁ  xed 
in 4% formaldehyde for 20 min. Labeling was performed according to 
standard protocols. Samples were mounted in Vectashield (Vector Labora-
tories) and were imaged using a confocal microscope (LSM 510; Carl 
Zeiss, Inc.) with the accompanying LSM5 software (Carl Zeiss, Inc.) at RT. 
Identical settings were used for control and experimental samples. In Fig. 1 
(B and C), a 40× 1.3 NA lens was used. In Figs. 3 (A, B, and D–K), 4 
(A and B), 5 H, 6 (A–D, G, and H), 7, S2 (B and C), S4 (A–C), and S5, 
a 63× 1.4 NA differential interference contrast plan-Neoﬂ  uor oil-immersion 
lens (Carl Zeiss, Inc.) was used. For Figs. 3 C, S2 A, and S3 A, a 10× 
0.45 NA lens without oil was used. Captured images were processed using 
Amira 2.2 (Mercury Computer Systems) followed by Photoshop 7.0 
(Adobe). Samples for Western blots were prepared by dissecting third 
instar larval brains and extracting proteins in radioimmunoprecipitation 
assay buffer with proteinase inhibitors on ice. Samples were then boiled 
in sample buffer for 5 min.
Antibodies that recognize the following proteins were used at 
the indicated dilutions for immunohistochemistry/Western blotting: Syt I 
at 1:5,000/1:10,000 (Littleton et al., 1993), n-Syb at 1:200/1:1,000, 
CSP at 1:100/1:1,000 (Zinsmaier et al., 1994), and SNAP25 at 
1:200/1:1,000 (Vilinsky et al., 2002). The following antibodies were used 
only for immunohistochemistry: DLG (mouse mAb 4F3) at 1:50 (Parnas 
et al., 2001), DLG (rabbit polyclonal; provided by K. Choi, Baylor College 
of Medicine, Houston, TX) at 1:500, HRP (rabbit; Jackson ImmunoResearch 
Laboratories) at 1:200, mouse mAb 24B10 (Futsch) at 1:50, mouse mAb 
nc82 (Bruchpilot) at 1:100 (Kittel et al., 2006), Fasciclin II (mouse mAb 
1D4) at 1:10 (Zito et al., 1997), GluRIII rabbit polyclonal (provided by 
A. DiAntonio, Washington University, St. Louis, MI) at 1:5,000 (Marrus et al., 
2004), and GFP (rabbit; Invitrogen) at 1:500. AlexaFluor488- (Invitrogen) 
and Cy3 (Jackson ImmunoResearch Laboratories)-conjugated secondary 
antibodies were used at 1:250. HRP-conjugated antibodies (Jackson 
  ImmunoResearch Laboratories) were used at 1:2,500 for Western blotting. 
Western blots were developed with ECL reagents (PerkinElmer).
Quantiﬁ  cation
For synaptic protein quantiﬁ  cation, anti-DLG (rabbit or mouse) was used to 
outline type I boutons (Lahey et al., 1994). Boutons were scanned with z steps 
of 0.5 μm. Using Amira software, the DLG-stained type I boutons in each con-
focal slice were highlighted, and the mean pixel intensity of all slices of the 
highlighted boutons of each NMJ were computed. Background ﬂ  uorescence 
in muscle areas adjacent to the boutons was quantiﬁ  ed similarly, and the 
background was subtracted from the bouton values to yield the mean intensity 
of labeling in the boutons. The mean value from at least three mutant NMJs 
was then expressed as a percentage of the corresponding control value.
ERG assay
ERGs were performed as described previously (Fabian-Fine et al., 2003; 
Verstreken et al., 2003); ﬂ  ies were immobilized with one eye and part 
of the thorax in a small drop of Elmer’s school glue on a microscope slide. 
For the 3L screen,  50–100 male F1 ﬂ  ies were subjected to two ERG record-
ings. Flies with mutant ERGs were liberated and subsequently mated.
Electrophysiology and FM 1-43 dye uptake
For FM 1-43 dye uptake experiments and electrophysiological recordings, 
third instar larvae were dissected in modiﬁ  ed HL3 without Ca
2+, and motor 
neurons were cut. Larvae were stimulated in modiﬁ  ed HL3 solution at ambi-
ent temperature with 4 μM FM 1-43, 90 mM KCl, and 1.5 mM Ca
2+ for 
1 min and were washed with modiﬁ  ed HL3 solution. Images were captured 
using a microscope (Axioskop; Carl Zeiss, Inc.) with Axiovision 4.2 software 
(Carl Zeiss, Inc.), a 40× 0.75-W water immersion lens (Carl Zeiss, Inc.), 
and a camera (MRm; Carl Zeiss, Inc.) at RT. The intensity of FM 1-43 was 
analyzed and quantiﬁ  ed as described previously (Verstreken et al., 2007).
EJPs and miniature EJPs recorded the membrane potential of muscle 6 
using sharp 90–110 MΩ electrodes as described previously (Koh et al., 
2004). The temperature of the preparations was controlled as described 
previously (Koh et al., 2004). The data were analyzed by Clampﬁ  t (MDS 
Analytical Technologies) for EJPs and by Mini Analysis Program 6.0.3 
(Synaptosoft) for miniature EJPs.
TEM
TEM of PRs and NMJ boutons was performed as described previously 
  (Verstreken et al., 2003). Images were captured using a transmission elec-
tron microscope (model 1010; JEOL) with a camera (US1000; Gatan) and 
digital micrograph. For the PRs and NMJ boutons, 3,000× and 8,000× 
magniﬁ  cations were used, respectively. For statistical analyses, cross sec-
tions of 10 cartridges or boutons from three different animals were mea-
sured using ImageJ (National Institutes of Health).
Depalmitoylation assay
Third instar larvae from control and mutant animals were homogenized in 
lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 5 mM EDTA, pH 7.4, and 
2% Triton X-100). After centrifugation at 16,000 g, the proteins in the 
  soluble fraction were precipitated by the chloroform-methanol precipitation 
method. The pellet was resuspended in SDS lysis buffer (50 mM Tris-Cl, 
5 mM EDTA, and 4% SDS) and treated with 150 mM NaCl and 2% Triton 
X-100 with or without 1 M hydroxylamine, pH 7.0, at ambient for 2 h. 
After hydroxylamine treatment, samples were boiled in SDS sample buffer 
and subjected to SDS-PAGE.
Online supplemental material
Fig. S1 shows that control and 3L1 mutant PR terminals in the lamina are 
correctly organized. Fig. S2 shows that CtermGFP-HIP14 is enriched in the 
CNS and synaptic terminal similar to NtermGFP-HIP14 and that GFP-HIP14 
is colocalized with the SV marker n-Syb at NMJs. Fig. S3 shows the mis-
localization of SNAP25 in hip14 mutants (A) and SSP in csp mutants (B) at 
the VNC. Fig. S4 shows the expression level of CSP2 and SybTMD-CSP2. 
Fig. S5 shows that SNAP25 levels are not restored in hip14 mutant larvae 
that overexpress SybTMD-CSP2, indicating that the mislocalization of 
SNAP25 in hip14 mutants is not caused by CSP reduction at the synaptic 
terminal. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200710061/DC1.
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